umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Risks associated with drug-eluting stents.
Umeå University, Faculty of Medicine, Public Health and Clinical Medicine. (Kardiologi)
2007 (English)In: Lancet, ISSN 1474-547X, Vol. 369, no 9575, 1785-1786 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 369, no 9575, 1785-1786 p.
Keyword [en]
Humans, Platelet Aggregation Inhibitors/administration & dosage/*therapeutic use, Risk Assessment, Stents/adverse effects, Thrombosis/etiology/*prevention & control, Time Factors
Identifiers
URN: urn:nbn:se:umu:diva-8747DOI: doi:10.1016/S0140-6736(07)60804-6PubMedID: 17531876OAI: oai:DiVA.org:umu-8747DiVA: diva2:148418
Available from: 2008-02-08 Created: 2008-02-08 Last updated: 2009-08-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17531876&dopt=Citation

Search in DiVA

By author/editor
Eriksson, Peter
By organisation
Public Health and Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 50 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf